CANY
MRK icon

Caxton Associates (New York)’s Merck MRK Stock Holding History

Caxton Associates (New York)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,890
Closed -$1.92M – 604
2024
Q3 		$1.92M Sell
16,890
-6,251
-27% -$743K 0.07% 131
2024
Q2 		$2.86M Buy
23,141
+1,701
+8% +$219K 0.1% 110
2024
Q1 		$2.83M Buy
+21,440
New +$2.64M 0.16% 87
2023
Q3 		– Sell
-13,061
Closed -$1.51M – 541
2023
Q2 		$1.51M Buy
13,061
+9,630
+281% +$1.09M 0.22% 99
2023
Q1 		$365K Buy
+3,431
New +$370K 0.06% 320
2022
Q3 		– Sell
-15,089
Closed -$1.38M – 601
2022
Q2 		$1.38M Buy
15,089
+12,468
+476% +$1.11M 0.13% 69
2022
Q1 		$215K Buy
+2,621
New +$207K 0.02% 435
2021
Q2 		– Sell
-4,192
Closed -$308K – 557
2021
Q1 		$308K Buy
+4,192
New +$309K 0.03% 273
2020
Q3 		– Sell
-2,855
Closed -$211K – 442
2020
Q2 		$211K Buy
+2,855
New +$215K 0.02% 361
2019
Q2 		– Sell
-2,837
Closed -$225K – 483
2019
Q1 		$225K Buy
+2,837
New +$212K 0.03% 316
2018
Q2 		– Sell
-23,094
Closed -$1.2M – 444
2018
Q1 		$1.2M Buy
23,094
+2,862
+14% +$155K 0.06% 165
2017
Q4 		$1.09M Buy
+20,232
New +$1.12M 0.05% 199
2017
Q3 		– Sell
-9,432
Closed -$577K – 579
2017
Q2 		$577K Buy
9,432
+1,153
+14% +$70.2K 0.02% 280
2017
Q1 		$502K Buy
+8,279
New +$502K ﹤0.01% 243
2013
Q3 		– Sell
-5,240
Closed -$232K – 210
2013
Q2 		$232K Buy
+5,240
New +$234K 0.01% 142

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Caxton Associates (New York)'s MRK Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Merck (MRK) in Q4 2024, closing a stake of 16,890 shares — an estimated $1.92M sold.

Caxton Associates (New York) first reported a position in MRK in Q2 2013 and held it in 15 quarters. The position peaked at $2.86M in Q2 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 16,890 Merck shares in Q4 2024, an estimated $1.92M.
  • Caxton Associates (New York) first reported a position in Merck in Q2 2013 and held it in 15 quarters.
  • Caxton Associates (New York)'s Merck position peaked at $2.86M in Q2 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.